Bioverge
San Francisco, US · Delaware corporation · 1 known investors
Founders & leadership
RG
Richard GibbExecutive Officer
NL
Neil LittmanExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$148.5KraisedMay 2023 · 4 investors · Other TechnologyRule 506(b)
▶$148.5KraisedMay 2023 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neil LittmanExecutive Officer, Director
- Richard GibbExecutive Officer
- Offering amount
- $148.5K
- Amount sold
- $148.5K
- Minimum investment
- $5K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$775KraisedMay 2023 · 21 investors · Other TechnologyRule 506(b)
▶$775KraisedMay 2023 · 21 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Neil LittmanExecutive Officer, Director
- Richard GibbExecutive Officer
- Offering amount
- $775K
- Amount sold
- $775K
- Minimum investment
- $5K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$588.5KraisedMay 2023 · 23 investors · Other TechnologyRule 506(b)
▶$588.5KraisedMay 2023 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Richard GibbExecutive Officer
- Neil LittmanExecutive Officer, Director
- Offering amount
- $600K
- Amount sold
- $588.5K
- Minimum investment
- $5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.